Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

SHSE:600329 Rapporto sulle azioni

Cap. di mercato: CN¥22.3b

Tianjin Pharmaceutical Da Ren Tang Group Gestione

Gestione criteri di controllo 1/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Lei Wang

Amministratore delegato

CN¥2.6m

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEO2.3yrs
Proprietà del CEOn/a
Durata media del management2.4yrs
Durata media del Consiglio di amministrazione2.9yrs

Aggiornamenti recenti sulla gestione

Recent updates

Are Investors Undervaluing Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHSE:600329) By 48%?

Oct 27
Are Investors Undervaluing Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHSE:600329) By 48%?

Why Investors Shouldn't Be Surprised By Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited's (SHSE:600329) 36% Share Price Surge

Oct 08
Why Investors Shouldn't Be Surprised By Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited's (SHSE:600329) 36% Share Price Surge

Some Shareholders Feeling Restless Over Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited's (SHSE:600329) P/E Ratio

Jul 26
Some Shareholders Feeling Restless Over Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited's (SHSE:600329) P/E Ratio

Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Has A Rock Solid Balance Sheet

Jul 05
Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Has A Rock Solid Balance Sheet

Fewer Investors Than Expected Jumping On Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHSE:600329)

Apr 18
Fewer Investors Than Expected Jumping On Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHSE:600329)

Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Has A Rock Solid Balance Sheet

Mar 18
Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Has A Rock Solid Balance Sheet

AMMINISTRATORE DELEGATO

Lei Wang (53 yo)

2.3yrs

Mandato

CN¥2,625,100

Compensazione

Ms. Lei Wang serves as Executive Director of Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited since December 30, 2022 and serves as its General Manager since August 22, 2022. She served as Gene...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Lei Wang
GM & Executive Director2.3yrsCN¥2.63mNessun dato
Jian Ma
Chief Financial Officer1.3yrsCN¥190.30kNessun dato
Hong Zhou
Deputy GM5.5yrsCN¥1.38m0.0031%
CN¥ 690.2k
Min Guo
Executive Directorno dataNessun datoNessun dato
Yu Zhang
Chief Manufacturing Officer2.6yrsCN¥893.80kNessun dato
Mingjie Shang
Executive Directorless than a yearCN¥299.00kNessun dato
Yan Jiao
Secretary to the Board of Directors16.9yrsCN¥445.80k0.0013%
CN¥ 294.9k

2.4yrs

Durata media

53yo

Età media

Gestione esperta: Il team dirigenziale di 600329 è considerato esperto (durata media dell'incarico 2.4 anni).


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Lei Wang
GM & Executive Director1.9yrsCN¥2.63mNessun dato
Hong Zhou
Deputy GM5.5yrsCN¥1.38m0.0031%
CN¥ 690.2k
Min Guo
Executive Director3.3yrsNessun datoNessun dato
Mingjie Shang
Executive Director1.4yrsCN¥299.00kNessun dato
Yoke Pheng Liew
Independent & Non-Executive Director4.4yrsCN¥259.16kNessun dato
Yuanxia Wang
Chairman of Board of Supervisors4.9yrsNessun datoNessun dato
Jianhua Xing
Supervisor2.9yrsNessun datoNessun dato
Mingrui Zhang
Non-Executive & Non-Independent Chairman2.9yrsNessun datoNessun dato
Weiwen Mao
Non-Executive Non-Independent Director1.9yrsNessun datoNessun dato
Guat Kwang Yeo
Lead Independent Directorless than a yearNessun datoNessun dato
Ming Zhong
Independent Directorless than a yearNessun datoNessun dato

2.9yrs

Durata media

53yo

Età media

Consiglio di amministrazione esperto: Il consiglio di amministrazione di 600329 non è considerato esperto (durata media del mandato 2.9 anni), il che suggerisce un nuovo consiglio.